We enrolled 800 infants (mean [±SD] birth weight, 715±167 g; mean gestational age, 24.9±1.5 weeks). Survival without moderate or severe bronchopulmonary dysplasia at 36 weeks occurred in 66 of ...

Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. The effects of inhaled glucocorticoids on out ...

A randomized controlled trial evaluates the safety of furosemide in preterm infants at risk of bronchopulmonary dysplasia. Findings from the study will be presented during the Pediatric Academic ...

Allergic bronchopulmonary aspergillosis occurs in patients with bronchial asthma or cystic fibrosis. This case series explores its clinical presentation and diagnostic challenges.

US-based biotechnology company Airway Therapeutics is to launch a multinational Phase III clinical trial of zelpultide alfa, a drug designed to prevent bronchopulmonary dysplasia (BPD) in preterm ...

An artificial neural network demonstrated high accuracy in detecting bronchopulmonary dysplasia in infants using air flow data, according to a presentation at the European Respiratory Society ...

Allergic bronchopulmonary aspergillosis (ABPA), if not diagnosed and treated early, can cause life-threatening complications. Current immunodiagnostic methods have been complicated by poorly ...

NEW DELHI: Abnormal lung tissue growth, a birth defect, is seen in nearly one in 1,000 newborns.In most cases, doctors say, the condition referred to as bronchopulmonary sequestration (BPS), does ...